Assessing patients with lupus: towards a drug responder index.
about
Androgen supplementation in older women: too much hype, not enough data.B cell depletion in autoimmune disease.Linguistic Validation of the LupusQoL for the Assessment of Quality of Life in Iranian Patients with Systemic Lupus Erythematosus.New classification criteria for systemic lupus erythematosus correlate with disease activityAnti-DNA antibodies--overview of assays and clinical correlations.Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now?The ACR nomenclature for CNS lupus revisited.Treatment of inflammatory myopathies.Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases.Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus.Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus.Weight loss and improvements in fatigue in systemic lupus erythematosus: a controlled trial of a low glycaemic index diet versus a calorie restricted diet in patients treated with corticosteroids.Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan.Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus.
P2860
Q30702926-11076011-E63A-4A3E-8D09-335BA4E0910FQ33361142-7457DA40-1745-4EB1-9C91-1DD975E9C28FQ34234020-AB5407A9-6E96-4829-B905-296DB99F13EFQ34492782-A595510A-E287-4358-B815-59A40B398E70Q35045844-58A65096-971F-44FA-81B2-AD48AAA9526AQ35045883-941555F4-B371-41A0-90DC-977257370106Q35625216-B3760B5A-0B0C-4813-AA10-D2DC940136F6Q36528220-3858F160-E31F-4FF3-B3B1-830D2472FF2DQ38697343-F9CBCB90-D8A6-4A45-8708-533E2B07B016Q41698087-C2A42311-A880-4D9B-854A-59E8B8DCC0F6Q44470266-F508F576-553B-4DE8-8D59-562FD43C78E4Q46374758-B9A97373-0FEC-4528-80AF-D9E082CC90C4Q47327623-1E21459A-CDB2-41CF-ACD9-70C975B56DA3Q47622606-82FE9739-968E-4152-AEBD-709ADAA001EFQ51920376-9F2DC724-CF10-4538-AFC3-113B2B889925
P2860
Assessing patients with lupus: towards a drug responder index.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Assessing patients with lupus: towards a drug responder index.
@ast
Assessing patients with lupus: towards a drug responder index.
@en
type
label
Assessing patients with lupus: towards a drug responder index.
@ast
Assessing patients with lupus: towards a drug responder index.
@en
prefLabel
Assessing patients with lupus: towards a drug responder index.
@ast
Assessing patients with lupus: towards a drug responder index.
@en
P2860
P356
P1433
P1476
Assessing patients with lupus: towards a drug responder index.
@en
P2093
Ramsey-Goldman R
P2860
P304
P356
10.1093/RHEUMATOLOGY/38.11.1045
P577
1999-11-01T00:00:00Z